Exhibit 8.1

Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017		212 450 4000 tel 212 701 5800 fax

February 27, 2015

Wells Fargo & Company,

420 Montgomery Street,

San Francisco, California 94104

Ladies and Gentlemen:

We have acted as special tax counsel to Wells Fargo & Company, a Delaware corporation (the “Company”), in connection with the issuance of (i) $155,000 aggregate face amount of Medium-Term Notes, Series K, Principal at Risk Securities Linked to the iShares^® MSCI Emerging Markets ETF, as described in the Company’s Pricing Supplement No. 479 dated February 20, 2015 (“Pricing Supplement 479”) to the Prospectus Supplement dated April 13, 2012 (the “Prospectus Supplement”) and the Prospectus dated April 13, 2012 (the “Prospectus”) contained in the Registration Statement on Form S-3, File No. 333-180728 (the “Registration Statement”) and (ii) $27,300,000 aggregate principal amount of Medium-Term Notes, Series K, Notes Linked to the 10-Year Constant Maturity Swap Rate due February 27, 2025, as described in the Company’s Pricing Supplement No. 481 dated February 24, 2015 (“Pricing Supplement 481”) to the Prospectus Supplement and the Prospectus contained in the Registration Statement. We hereby confirm our opinion as set forth under the heading “United States Federal Tax Considerations” in Pricing Supplement 479 and Pricing Supplement 481.

We hereby consent to the reference to us under the heading “United States Federal Tax Considerations” in Pricing Supplement 479 and Pricing Supplement 481 and to the filing of this opinion as an exhibit to a Current Report on Form 8-K of the Company filed with the Securities and Exchange Commission and thereby incorporated by reference into the Company’s Registration Statement. In giving such consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended.

Very truly yours,